The Government is to provide $50 million over three years to fund research into the causes of lung cancer, the National Cancer Institute (NCI) has announced.
The announcement was made at the opening of a $500 million biotechnology and pharmaceutical innovation fund that will be led by the Australian Institute of Health and Welfare.
The fund is expected to be announced at the end of next year.
“We are committed to the pursuit of new approaches and technologies for tackling the causes and treatments of lung cancers, particularly among men, and we want to accelerate that progress by providing an effective, efficient and long-term solution,” said NCA Director-General Tony Archer.
“This funding will support a diverse range of research initiatives to develop novel therapies and improve outcomes for men and their families.”
Lung cancer is a complex disease and can be caused by a number of different types of cells, including normal and malignant cells.
It can be treated by immunotherapy or radiotherapy.
The National Cancer Agency’s Lung Cancer Research and Surveillance Network is working to identify new treatment targets and develop new tools and tests.
The agency said the new fund would support the development of a “well-rounded strategy for lung cancer research and treatment”.
“The new funding will provide a range of tools and tools for clinical trials, clinical trial management, drug discovery, regulatory monitoring and the development and use of innovative drugs,” the NCA said.
“These tools and strategies will support the national focus on the development, testing and commercialisation of novel treatments and the nationalisation of drugs that have the potential to improve men’s lives.”
Lung Cancer is the leading cause of cancer death in Australia and affects almost one in five men and women.
The NCA’s Lung Research and Prevention Centre in Canberra was set up in 2012 to develop the country’s most comprehensive lung cancer registry, the Australia Lung Cancer Registry, to provide better cancer data, to coordinate national research, and to help develop a better understanding of the underlying causes of cancer.
The NCCSRC has received a total of $1.6 billion from the Australian Health Fund since it was established in 2010.